Session 8C: From Concept to Clinic – Supporting Manufacturing Success
Tracks
Track 3
| Thursday, October 23, 2025 |
| 2:30 PM - 3:15 PM |
| Momentum Room |
Details
This session explores how manufacturers can play a pivotal role in bringing therapeutic products — including drugs, biologics, and medical devices — from concept to clinic trial. We’ll examine the unique challenges faced in early-stage development, the importance of strategic vendor selection, and the complexities of scaling production to meet clinical trial demands and derisk future commercial deliverables.
Key topics will include:
• Navigating regulatory and quality requirements across the clinical development pipeline
• Aligning manufacturing processes with clinical trial timelines
• Building resilient supply chains and partnerships locally and internationally
• Leveraging Australia’s strengths in onshore manufacturing, including regulatory agility, skilled workforce, and infrastructure
Attendees will gain insights into how proactive engagement across the development lifecycle can accelerate timelines, reduce risk, and enhance product quality — ultimately supporting successful clinical trials.
Speaker
Dr. Jan Bekker
Vice President of Business Development and Commercial Operations
BioCina
Panellist
Mrs Justine Mann
Chief Executive Officer
CBE Pure Solutions
Chair
Mr Stephen Thompson
CEO
Viral Vector Manufacturing Facility
Panellist